Vici, Patrizia <br/><br/>
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study.  [electronic resource] 

 -  Journal of experimental & clinical cancer research : CR  Apr 2011 
 - 39 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1756-9966 
<br/><br/><label>Standard No.: </label>10.1186/1756-9966-30-39  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alopecia--chemically induced<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bone Neoplasms--drug therapy<br/>Breast Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Epirubicin--administration & dosage<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Polyethylene Glycols--administration & dosage<br/>Prospective Studies<br/>Soft Tissue Neoplasms--drug therapy<br/>Vinblastine--administration & dosage<br/>Vinorelbine<br/>Viscera--pathology